Clinical Trials Logo

Secondary Open Angle Glaucoma clinical trials

View clinical trials related to Secondary Open Angle Glaucoma.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT00739154 Not yet recruiting - Clinical trials for Primary Open Angle Glaucoma

Protective Effect of Phenytoin on Glaucoma

Start date: November 2008
Phase: N/A
Study type: Observational

since glaucoma is considered an optic neuropathy, new treatments for glaucoma are being continuously investigated, including neuroprotection. Previous studies implied that phenytoin, a potent anti-convulsive drug, has a neuroprotective role, and Na+ channels blockage was suggested as a possible mechanism. This study predicts that glaucoma patients taking Phenytoin will have a less advanced glaucoma as compared to patients not taking the drug. Glaucoma severity will be determined by visual acuity, visual fields, optic disc cupping and nerve fiber layer thickness